Product Code: ETC417505 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The corticosteroids market in the Philippines has witnessed significant expansion, driven by the rising prevalence of inflammatory and autoimmune conditions. Corticosteroids, known for their potent anti-inflammatory properties, find application in treating a range of diseases such as asthma, arthritis, and dermatological disorders. The market`s growth is also attributed to increasing healthcare access, improved patient awareness, and advancements in drug delivery methods. However, long-term usage of corticosteroids raises concerns about potential side effects, making proper prescription practices and patient education vital components of market dynamics.
The Philippines corticosteroids market is driven by the pharmaceutical industry`s use of corticosteroid medications for their anti-inflammatory and immunosuppressive properties. Corticosteroids are used to treat a wide range of conditions, including allergies, asthma, autoimmune disorders, and skin conditions. The market`s growth is influenced by the prevalence of these health issues, healthcare infrastructure, and advancements in drug delivery methods. Regulatory approvals, clinical research, and patient preferences also play a role in shaping the market`s direction.
The Philippines corticosteroids market encounters challenges associated with balancing therapeutic benefits with potential side effects. Corticosteroids are used for various medical conditions, but their long-term use can lead to adverse effects. Healthcare providers must carefully weigh the benefits and risks of corticosteroid treatment, ensure proper patient education, and monitor patients closely. Managing patient expectations, providing well-informed medical guidance, and promoting responsible prescribing practices are key challenges in this market.
The corticosteroids market in the Philippines could have experienced fluctuations during the pandemic. Corticosteroids are used in various medical treatments, including those related to inflammation and immune responses. Increased demand for treatments and therapies during the pandemic might have influenced market growth. However, supply chain disruptions, regulatory changes, and shifts in healthcare priorities could have affected production and distribution, impacting patient access to these drugs.
Some of the key players present in this sector include Abbot India Limited; Astellas Pharma US Inc. ; Mylan Pharmaceuticals Inc. ; GlaxoSmithKline Plc; Eisai Co Ltd; Cipla Inc. ; Merck Sharp & Dohme Corp. ; Novartis International AG; Sandoz International GmbH and Sun Pharmaceutical Industries LTD among others. To increase their presence in this segment these companies are emphasizing on product launches coupled with aggressive promotional activities across the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Corticosteroids Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Corticosteroids Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Corticosteroids Market - Industry Life Cycle |
3.4 Philippines Corticosteroids Market - Porter's Five Forces |
3.5 Philippines Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Philippines Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of skin disorders and autoimmune diseases in the Philippines |
4.2.2 Growing awareness about the benefits of corticosteroids in managing various medical conditions |
4.2.3 Technological advancements in drug delivery systems for corticosteroids |
4.3 Market Restraints |
4.3.1 Stringent government regulations and approval processes for corticosteroid products |
4.3.2 Side effects and risks associated with prolonged use of corticosteroids |
4.3.3 Competition from alternative treatment options such as herbal remedies and non-steroidal anti-inflammatory drugs (NSAIDs) |
5 Philippines Corticosteroids Market Trends |
6 Philippines Corticosteroids Market, By Types |
6.1 Philippines Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Philippines Corticosteroids Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 Philippines Corticosteroids Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.1.4 Philippines Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2021-2031F |
6.1.5 Philippines Corticosteroids Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.6 Philippines Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.1.7 Philippines Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
6.2 Philippines Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Philippines Corticosteroids Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 Philippines Corticosteroids Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.4 Philippines Corticosteroids Market Revenues & Volume, By Research Institutes, 2021-2031F |
6.2.5 Philippines Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
7 Philippines Corticosteroids Market Import-Export Trade Statistics |
7.1 Philippines Corticosteroids Market Export to Major Countries |
7.2 Philippines Corticosteroids Market Imports from Major Countries |
8 Philippines Corticosteroids Market Key Performance Indicators |
8.1 Patient adherence rate to corticosteroid treatment plans |
8.2 Number of dermatologists and healthcare professionals prescribing corticosteroids |
8.3 Rate of new product development and introduction in the corticosteroids market |
8.4 Research and development investments in corticosteroid formulations and delivery methods |
8.5 Patient satisfaction and feedback on corticosteroid treatment effectiveness |
9 Philippines Corticosteroids Market - Opportunity Assessment |
9.1 Philippines Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Philippines Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Corticosteroids Market - Competitive Landscape |
10.1 Philippines Corticosteroids Market Revenue Share, By Companies, 2024 |
10.2 Philippines Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |